Amplitude Ventures related stories
All articles and analysis
LPs build new relationships amid challenges for VCWe spoke to a dozen LPs for our cover story. They are upbeat about VC and, despite a lack of distributions, appear keen on supporting venture managers or pursuing new ones.
Northleaf Capital Partners raises C$370m for new FoFLimited partners include the government of Canada, which invested through BDC Capital, Canada Pension Plan Investment Board (CPP Investments), as well as high-net-worth individuals and family offices.
Cell targeting startup Ability Biologics raises $12m in seed roundAbility was launched by Amplitude Ventures, working with co-founders Giles Day, CEO, and Jean-Philippe Bürckert, vice president of technology.
Fintech founders race toward finish line for Luge Capital's second fundThe Canadian early-stage investor plans to invest larger amounts in more kinds of fintech start-ups with its larger sophomore fund.
Venture-backed LeddarTech to gain Nasdaq listing with SPAC mergerBased in Quebec City, LeddarTech is an automotive software company that provides low-level sensor fusion and perception technology.
- Agritech startup ChrysaLabs secures $11m in Series A financing
ChrysaLabs is a Montreal-based agriculture technology startup providing portable, accurate and real-time soil data solutions.
- Recursion to buy AI-enabled drug discovery startups Cyclica, Valence
Recursion agreed to buy Toronto-based Cyclica for $40 million and Montreal-based Valence for $47.5 million.
- Radiant Biotherapeutics emerges from stealth mode, raises C$8m seed
The company was created by Amplitude Ventures, which also led the seed round alongside The Hospital for Sick Children, Amplitude's launch partner.
Cancer-focused Abdera Therapeutics collects $142m for Series A, B dealsVersant Ventures and Amplitude Ventures led the Series A round, while venBio Partners led the Series B round.
BDC Capital taps Sévrine Labelle as Thrive Lab managing directorThe C$100 million Thrive Lab will be launched officially in the spring of 2023.